EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective Study

Quentin Giai Gianetto iD, Valérie Michel, Thibaut Douché iD, Karine Nozeret iD, Aziz Zaanan, Oriane Colussi, Isabelle Trouilloud, Simon Pernot, Marie-Noelle Ungeheuer, Catherine Julié, Nathalie Jolly, Julien Taïeb iD und 3 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262010114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Quentin Giai Gianetto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, UAR CNRS 2024, Proteomics Core Facility, MSBio, 75015 Paris, France. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Blood Proteins, Precancerous Conditions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut Pasteur, Odyssey-Re, Institut Pasteur Paris through Pasteur International Concerted Action program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) often presents a poor prognosis due to its asymptomatic phenotype at early stages. Upper endoscopy, which is the current gold standard to diagnose GC, is invasive with limited sensitivity for detecting gastric preneoplasia. Non-invasive biomarkers, such as blood circulating proteins, offer a promising alternative for the early detection of gastric lesions. In this prospective study, we identified plasma protein biomarkers for gastric preneoplasia and cancer using mass spectrometry-based proteomics in an exploratory cohort (n = 39). Fifteen promising protein candidates emerged to distinguish patient categories and were further confirmed by enzyme-linked immunosorbent assays (ELISA) in plasma samples from a validation cohort of 138 participants. Our predictive models demonstrated high classification performance with a minimal set of biomarkers. A four-protein panel (ARG1, CA2, F13A1, S100A12) achieved 94.1–98.2% AUROC (95% CI) for distinguishing cancer from non-cancer cases, while a five-protein panel (ARG1, CA2, HPT, MAN2A1, LBP) reached 97.3–99.5% AUROC (95% CI) for distinguishing cancer or preneoplasia from healthy or non-atrophic gastritis cases on the full cohort. Leveraging simple blood sampling, this strategy holds promise to detect high-risk gastric lesions, even at asymptomatic stages. Such an approach could significantly improve early detection and clinical management of GC, offering direct benefit for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBiomarkers, TumorBlood ProteinsPrecancerous ConditionsHumansMaleFemaleProspective StudiesMiddle AgedEarly Detection of CancerAgedProteomicsAdult

Stichwörter der Autor:innen

diagnosisdysplasiaearly detectiongastric cancerintestinal metaplasialiquid biopsymass spectrometry-based proteomicpreventive strategies

Substanzen

Biomarkers, TumorBlood Proteins

Autor:innen und Institutionen

  • Institut Pasteur, Université Paris Cité, UAR CNRS 2024, Proteomics Core Facility, MSBio, 75015 Paris, France.
  • Institut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, 75015 Paris, France.
  • Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Infection, Genotoxicity and Cancer Team, 75015 Paris, France.
  • Assitance Publique-Hôpitaux de Paris, Université Paris-Cité, Georges Pompidou European Hospital, Department of Gastroenterology and Digestive Oncology, 75015 Paris, France.
  • Institut Pasteur, Center for Translational Research, Clinical Investigation and Access to Clinical Resources (ICAReB), 75015 Paris, France.
  • Assistance Publique-Hôpitaux de Paris, CHU Paris IdF Ouest, Pathology Unit Ambroise Paré Hospital, 92100 Boulogne Billancourt, France.

ORCID-Profile: Quentin Giai Gianetto, Thibaut Douché, Karine Nozeret, Julien Taïeb, Mariette Matondo, Eliette Touati

Förderung

  • Institut Pasteur
  • Odyssey-Re
  • Institut Pasteur Paris through Pasteur International Concerted Action program
  • Innovation Program Flash Maturation
  • Odyssey Reinsurance Company

Zitieren

APA

Giai Gianetto, Q., Michel, V., Douché, T., Nozeret, K., Zaanan, A., Colussi, O., Trouilloud, I., Pernot, S., Ungeheuer, M. N., Julié, C., Jolly, N., Taïeb, J., Lamarque, D., Matondo, M., & Touati, E. (2025). Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010114

Vancouver

Giai Gianetto Q, Michel V, Douché T, Nozeret K, Zaanan A, Colussi O, et al. Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010114

BibTeX
@article{GiaiGianetto2025,
  author = {Giai Gianetto, Quentin and Michel, Valérie and Douché, Thibaut and Nozeret, Karine and Zaanan, Aziz and Colussi, Oriane and Trouilloud, Isabelle and Pernot, Simon and Ungeheuer, Marie-Noelle and Julié, Catherine and Jolly, Nathalie and Taïeb, Julien and Lamarque, Dominique and Matondo, Mariette and Touati, Eliette},
  title = {Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262010114}
}
Kostenlos starten →